Use of Immunosuppressive Therapy for Sarcoidosis

University of Cincinnati2,000 enrolled

Overview

Retrospective review of the outcome of use of immunosuppressive drugs in treatment of sarcoidosis

Patients receiving one or more cytotoxic or other immunosuppressive drug will be observed

Study Type

OBSERVATIONAL

Enrollment

2,000

Observe patients versus treatment type

Sex: ALLMin age: 15 YearsMax age: 90 Years

Medical Language ↔ Plain English

Inclusion Criteria: Any patient treated for sarcoidosis Exclusion Criteria: * None

University of Cincinnati

Cincinnati, Ohio, United States

RECRUITING

Clinical Outcome

Number of participants with improvement over two years

Time frame: 2 years

Toxicity

Number of participants with adverse events

Time frame: 2 years

Robert P Baughman, MD

CONTACT

Felicia Thompson

CONTACT

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.